as 11-21-2024 4:00pm EST
Stocks
Bellevue Life Sciences Acquisition Corp is a blank check company.
Founded: | 2020 | Country: | United States |
Employees: | N/A | City: | BELLEVUE |
Market Cap: | 44.6M | IPO Year: | 2023 |
Target Price: | N/A | AVG Volume (30 days): | 5.8K |
Analyst Decision: | N/A | Number of Analysts: | N/A |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -0.09 | EPS Growth: | N/A |
52 Week Low/High: | $10.43 - $13.40 | Next Earning Date: | 01-01-0001 |
Revenue: | N/A | Revenue Growth: | N/A |
Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
BLAC Breaking Stock News: Dive into BLAC Ticker-Specific Updates for Smart Investing
The Telegraph
5 months ago
Motley Fool
5 months ago
AFP
5 months ago
Simply Wall St.
5 months ago
Simply Wall St.
5 months ago
Simply Wall St.
5 months ago
Simply Wall St.
5 months ago
Motley Fool
5 months ago
The information presented on this page, "BLAC BELLEVUE LIFE SCIENCES ACQ CORP - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.